Webinar: NRG-GI004 / SWOG S1610 COMMIT Study Amendment 9 Overview

April 18 2023

Two NRG-GI004/SWOG S1610 webinars are being offered to provide an update to research staff at sites participating in the GI004/S1610 trial. Protocol amendment 9 was activated on April 14, 2023. Dr. Caio Max Sao Rocha Lima, Co-Principal Investigator, along with Dr. Michael Overman, Co-Principal Investigator, will review the protocol changes which include updates to liberalize the eligibility criteria to help with accrual and to the statistical design to allow the trial to complete in 2 years.

These protocol overview sessions are intended for Principal Investigators and research staff who currently have NRG-GI004/SWOG-S1610 open at their site, as well as those interested in opening the protocol at their site in the future.We are offering the protocol overview sessions at two different times on Tuesday, May 16, 2023.

To register for one of the sessions, please click on the time you want to attend and fill in the registration information.

WHEN: Tuesday, May 16, 2023:

10:00 am to 11:00 am (ET)


4:00 pm to 5:00 pm (ET)

The webinars will be held using Microsoft TEAMS. You will receive a calendar invite with the Teams links once you have registered for either webinar.

To view the Webinar Flyer, click here.

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.